Regeneron has won a court ruling that will make it harder for U.S. authorities to win a lawsuit accusing it of paying illegal ...

Regeneron settles patent lawsuit over protein for testing COVID-19 treatments December 16, 2024 AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed ...

A teen died and five others were injured after a shooting at a mansion party in the San Fernando Valley that took place early ...

Erste Group revised its stance on Regeneron (NASDAQ:REGN) Pharmaceuticals (NASDAQ:REGN), changing the stock's rating from Buy to Hold. The adjustment reflects concerns over a ...

Regeneron has started 2025 with an increase in defensive capital allocation - initiation of a dividend and an expanded share buyback program. Increased competitive pressure on the Eylea franchise ...

But this year, for the first time, we have a bigger, 6.3-inch iPhone 16 Pro model, while the regular version sticks with the smaller, 6.1-inch size from the past. Compact phone lovers might be ...

News of a significant earnings beat propelled Regeneron Pharmaceuticals (NASDAQ: REGN) to a nearly 5% share price gain on the second trading day of the week. The company posted its fourth-quarter ...

Regeneron Pharmaceuticals, Inc. REGN reported fourth-quarter 2024 earnings per share (EPS) of $12.07, which beat the Zacks Consensus Estimate of $11.62. The company recorded an EPS of $11.86 in ...

Looking for that perfect upgrade? We're on hand with a list of the very best iPhone 16 deals right here on this page. We've made sure to include plenty of options for all types of users ...